Patient # 2-6
EVENTPERIOD 1PERIOD 2PERIOD 3PERIOD 4PERIOD 5
1st qtr 1995 – 4th qtr 19951st qtr 1998 – 4th qtr 19981st qtr 1999 – 4th qtr 19991st qtr 2000 – 4th qtr 20001st qtr 2001 – 4th qtr 2001
Diagnosis/biopsy8/95
Surgery8/952/01
Radiation
Chemotherapy8/9512/95199810/011/014/01
Naltrexone9/00
CT scan8/004/01
Tumor markers8/9519988/9920007/01
8/01
CAM other199812/004/01

From: Appendix E: Additional Cases Reviewed

Cover of Best-Case Series for the Use of Immuno-Augmentation Therapy and Naltrexone for the Treatment of Cancer
Best-Case Series for the Use of Immuno-Augmentation Therapy and Naltrexone for the Treatment of Cancer.
Evidence Reports/Technology Assessments, No. 78.
Coulter I, Hardy M, Shekelle P, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.